Article | April 07, 2026 OIG Advisory Opinion 25-11: Key Compliance Insights for Manufacturers Read More
Article | March 24, 2026 OPDP’s 2026 Untitled Letters: Early Enforcement Trends in Prescription Drug Promotion Read More
Article | June 21, 2023 Beyond Paperwork: Assessing the Effectiveness of a Compliance Program Read More
Article | June 14, 2023 New WA Privacy Law ‘Turns The Beat Around’ on Drug and Device Makers Read More
Article | August 23, 2022 Are you Ready for Inspection? Best Practices to “Survive” FDA Inspections Read More
Article | August 08, 2022 Are you Submission Ready? FDA Medical Device Submission Tips & Tricks Read More
Article | December 13, 2021 9 Months After Mallory: Keeping Independent Contractors Independent Read More
Article | December 01, 2021 Are drug and device makers with weak cybersecurity violating the False Claims Act? Read More